SecBot SecBot

Equitable Community Access to Pharmacist Services Act

H.R. 1770 Rep. Adrian Smith (R-NE-3) In committee
Bill text PDF
  1. Introduced Mar 23
  2. Committee Mar 23
  3. Passed House Next
  4. Passed Senate Not yet
  5. To President Not yet
  6. Law Not yet
Where it stands
In committee, Mar 23, 2023Next: House vote
680d ago Dec 17, 2024: Referred to the Subcommittee on Health.
Final votes
No roll callsNo recorded vote on this bill yet
Lobbying
8companies, 18 filings
Subscribe to see spend
Member trades
13trades in the last 90 days
Subscribe to see who
Who backs the bill and who pushes back Subscribe

Companies lobbying on this bill

8 companies
Companies by sector
Medical Devices & Healthcare 4Consumer & Retail 3Biotech & Pharma 1
Search all 8 companies, their asks and price moves Subscribe

Summary

Equitable Community Access to Pharmacist Services Act

Full summary2 paragraphs

This bill expands Medicare coverage to permanently include services provided by a pharmacist, including incidental services and supplies, related to testing, vaccines, and treatment for COVID-19, influenza, and certain other illnesses.

Specifically, the bill provides for continued coverage of pharmacist services relating to evaluation and management of patients for testing and treatment for COVID-19, influenza, respiratory syncytial virus (RSV), or streptococcal pharyngitis (strep throat), as well as vaccines for pneumococcal disease, COVID-19, influenza, or hepatitis B. It also generally provides for coverage of pharmacist services during a public health emergency.

Library of Congress summary, Mar 23, 2023

Summary versions
  • Introduced in HouseMar 23, 2023

Official record from Congress.gov, the House Clerk and the Senate; lobbying from Lobbying Disclosure Act filings. Updated Oct 28, 2026.